Prescriptions

KMM..

KMM Paediatric INJ..

DescriptionLabetalol HCl is an adrenergic receptor blocking agents that have both selectivealpha1-adrenergic and nonselective beta adrenergic receptor blocking actions. Both the alpha and beta-blocking actions of orally administered Labetalol HCl contribute to a decrease in blood pressure in hyperte..

Labegest200 TabletDescriptionLabetalol HCl is an adrenergic receptor blocking agents that have both selectivealpha1-adrenergic and nonselective beta adrenergic receptor blocking actions. Both the alpha and beta-blocking actions of orally administered Labetalol HCl contribute to a decrease in blood p..

DescriptionThe precise mechanism(s) by which lamotrigine exerts its anticonvulsant action are unknown. Lamotrigine has an effect on sodium channels. Lamotrigine inhibits voltage-sensitive sodium channels, thereby stabilizing neuronal membranes and consequently modulating presynaptic transmitter rele..

Lamogin 5 Chewable Dispersible TabletDescriptionThe precise mechanism(s) by which lamotrigine exerts its anticonvulsant action are unknown. Lamotrigine has an effect on sodium channels. Lamotrigine inhibits voltage-sensitive sodium channels, thereby stabilizing neuronal membranes and consequently mo..

Lapacent 250 TabletDescriptionLapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both Epidermal Growth Factor Receptor (EGFR [ErbB1]) and of Human Epidermal Receptor Type 2 (HER2 [ErbB2]) receptors (estimated Kiapp values of 3nM and 13nM, respectivel..

DescriptionLemonika contains the active ingredient Citric Acid Monohydrate which helps to reduce the dry cough and soothes the throat from any related discomfort and pain. Citric Acid is a demulcent which relieves irritation of the mucous membrane in the throat by forming a protective film. Citric A..

DescriptionLenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer prog..

Lenvacent 4 CapsuleDescriptionLenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor grow..